07521423 is referenced by 19 patents and cites 27 patents.

Methods for reducing gastric motility and delaying gastric emptying for therapeutic and diagnostic purposes are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist. Methods for treating conditions associated with elevated, inappropriate, or undesired post-prandial blood glucose levels are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist alone or in conjunction with other anti-gastric emptying agents.

Title
Exendin pharmaceutical compositions
Application Number
10/896244
Publication Number
7521423 (B2)
Application Date
July 20, 2004
Publication Date
April 21, 2009
Inventor
Bronislava Gedulin
Del Mar
CA, US
Andrew A Young
La Jolla
CA, US
Assignee
Amylin Pharmaceuticals
CA, US
IPC
C07K 5/00
A61K 38/00
View Original Source